NEW YORK, NY / ACCESSWIRE / May 7, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at …
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Acacia Communications, Inc. (“Acacia”) (NASDAQ:ACIA) between August 11, 2016 and July 13, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Massachusetts. …
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of RH (formerly known as Restoration Hardware) (NYSE: RH) between March 26, 2015 to June 8, 2016. You are hereby notifiedthat a securities class action lawsuit has been commenced in the USDC for the Northern District of …
Statements of defence from both deny blame over faulty hair tests used in court to remove children from their parents. He rejects the findings of an independent review led by retired Court of Appeal Justice Susan Lang last year, which harshly criticized hair testing procedures at Motherisk. “The hair testing methodologies employed by (Motherisk) were, at all material times, accurate and …
Theranos, the revolutionary blood testing company founded by Stanford dropout and Silicon Valley wonder Elizabeth Holmes, is having a bad year. The company is under investigation for securities fraud, in June its pharmacy chain partner Walgreens broke ties and shut down all …
A Vancouver lawyer who’s filed a class-action lawsuit against the makers of Cold-FX, says manufacturers knew the product wasn’t more effective than placebos and withheld research that came to that conclusion. John Green has filed lawsuits in British Columbia and Saskatchewan – if the case is approved in Saskatchewan, it could have nationwide implications. He says that if the cases succeed, in a …
The makers of Cold-FX have sat for years on a study that suggested Canada’s most popular cold and flu remedy was no more effective than a placebo in treating symptoms of the viruses. The 2004 trial was conducted by Dr. Gerry Predy, a top Alberta public-health official, at a time when the supplement’s makers told consumers the product would bring fast relief from the effects of such ailments. …